极低碘对比剂指导冠心病合并慢性肾功能不全介入治疗研究进展
Research progress on ultra-low contrast-guided percutaneous coronary interventions in the treatment of coronary heart disease combined with chronic renal insufficiency
王宁远 1王威 1辛倩 1高磊1
作者信息
- 1. 中国人民解放军总医院第六医学中心心血管病医学部,北京 100048
- 折叠
摘要
临床中约10％的患者在接触碘对比剂后会发生对比剂肾病,而对于既往存在肾功能不全者对比剂肾病的发生率可高达40％.严重的对比剂肾病会导致肾功能短时间内急剧恶化,从而诱发严重的不良临床事件.目前临床上已有多种策略可用于预防对比剂肾病的发生,其中减少碘对比剂的剂量是避免对比剂肾病发生的关键.基于此有学者提出了"极低碘对比剂"指导经皮冠状动脉介入治疗这一策略,旨在最大程度减少冠状动脉介入术中碘对比剂的用量.本文就该策略作一综述.
Abstract
Contrast-induced nephropathy occurs in 10％～40％of patients exposed to intravascular radiographic contrast agents.It may results in a rapid decline in kidney function,which lead to serious adverse events.Various measures have been used to lessen the occurrence of contrast-induced nephropathy,and it is essential to reduce contrast volume.According to this,the strategy"ultra-low contrast"has been proposed,aiming to minimize the amount of contrast during the intervention.This article provides a review of this strategy.
关键词
极低碘对比剂/对比剂肾病/经皮冠状动脉介入治疗Key words
Ultra-low contrast/Contrast-induced nephropathy/Percutaneous coronary intervention引用本文复制引用
基金项目
解放军总医院第六医学中心创新培育基金(CXPY202312)
出版年
2024
NETL
NSTL
万方数据